Patents by Inventor Usha Patel

Usha Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
    Publication number: 20050176706
    Abstract: Compounds of Formula (IA), (IB), (IC), and (ID) wherein R1, R2, R3, R4, R5, and R6 are as respectively defined herein for Formula (IA), (IB), (IC), and (ID), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
    Type: Application
    Filed: September 22, 2004
    Publication date: August 11, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Younes Bekkali, Rajashekhar Betageri, Michel Emmanuel, Abdelhakim Hammach, Christian Joachim Harcken, Thomas Kirrane, Daniel Kuzmich, Thomas Lee, Pingrong Liu, Usha Patel, John Proudfoot, Hossein Razavi, Doris Riether, Hidenori Takahashi, David Thomson, Ji Wang, Renee Zindell
  • Src family SH2 domain inhibitors
    Patent number: 6284768
    Abstract: This invention relates to compounds of formula (I): wherein Ring a, A, B, C, D, E, R and Q are defined herein. These compounds possess the ability to disrupt the interaction between regulatory proteins possessing one or more SH2 domains and their native ligands.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: September 4, 2001
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Rajashekhar Betageri, Pierre L. Beaulieu, Jean-Marie Ferland, Montse Llinas-Brunet, Neil Moss, Usha Patel, John R. Proudfoot, Mario Cardozo
  • Src family SH2 domain inhibitors
    Patent number: 6268365
    Abstract: This invention relates to compounds of formula (1): wherein Ring a, A, B, C, D, E, R and Q are defined herein. These compounds possess the ability to disrupt the interaction between regulatory proteins possessing one or more SH2 domains and their native ligands.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: July 31, 2001
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Rajashekhar Betageri, Pierre L. Beaulieu, Jean-Marie Ferland, Montse Llinas-Brunet, Neil Moss, Usha Patel, John R. Proudfoot, Mario Cardozo
  • Src family SH2 domain inhibitors
    Patent number: 6054470
    Abstract: This invention relates to compounds of formula (1): ##STR1## wherein Ring a, A, B, C, D, E, R and Q are defined herein. These compounds possess the ability to disrupt the interaction between regulatory proteins possessing one or more SH2 domains and their native ligands.
    Type: Grant
    Filed: December 9, 1998
    Date of Patent: April 25, 2000
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Rajashekhar Betageri, Pierre L. Beaulieu, Jean-Marie Ferland, Montse Llinas-Brunet, Neil Moss, Usha Patel, John R. Proudfoot, Mario Cardozo
  • 2-heteroaryl-5,11-dihydro-6H-dipyrido?3,2-B:2',3'-E!?1,4!diazepines and their use in the prevention or treatment of HIV infection
    Patent number: 5837704
    Abstract: Novel compounds for the treatment of HIV-1 infection. These are 2-heteroary-5,11-dihydro-6H-dipyrido?3,2-b:2',3'-e!?1,4!diazepines of the formula ##STR1## wherein Z is oxygen, sulfur, .dbd.NCN or .dbd.NOR.sup.
    Type: Grant
    Filed: August 1, 1996
    Date of Patent: November 17, 1998
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Karl Hargrave, John Proudfoot, Usha Patel, Suresh Kapadia, Terence Kelly, Daniel McNeil, Mario Cardozo